Get started
Author

Amy C. M. Musiek

Observed names: A. Musiek, A.C. Musiek, Amy C M Musiek, Amy C Musiek, Amy C. Musiek, Amy C.M. Musiek, Amy Musiek
Observed institutions: Barnes-Jewish Hospital, Vanderbilt University, Washington University in St. Louis, Hospital of the University of Pennsylvania, Canakkale Onsekiz Mart Universitesi Tip Fakultesi Hastanesi, VA Tennessee Valley Healthcare System, Istituto Tumori Bari, University of Pennsylvania Health System, University of Pennsylvania
ORCID: 0000-0003-3745-6223
Observed ORCID: 0000-0003-3745-6223
OpenAlex ID: A5046355746
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
2018 · Youn H Kim, Martine Bagot, et al. · The Lancet Oncology · 669
PDF
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
2018 · Rizwan Romee, Sarah Cooley, et al. · Blood · 409
PDF
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States
2018 · Robert G. Micheletti, Zelma Chiesa-Fuxench, et al. · Journal of Investigative Dermatology · 145
PDF
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10
2019 · Megan H. Noe, Misha Rosenbach, et al. · JAMA Dermatology · 118
PDF
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
2025 · David Fiorentino, Aaron R Mangold, et al. · The Lancet · 56
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
2022 · Ellen J. Kim, Aaron R. Mangold, et al. · JAMA Dermatology · 55
Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus
2018 · Anniek Zaalberg, Sara Moradi Tuchayi, et al. · Journal of Investigative Dermatology · 54
PDF
Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: Diagnostic implications
2014 · Andy C. Hsi, Sena J. Lee, et al. · Journal of the American Academy of Dermatology · 51
Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response
2019 · Lu Chen, Kenneth R. Carson, et al. · JAMA Dermatology · 48
PDF
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
2021 · Amy C. M. Musiek, Kerri E. Rieger, et al. · Dermatology and Therapy · 46
PDF
Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma
2014 · Rachel L. Kyllo, Mary Kendall Parker, et al. · Journal of the American Academy of Dermatology · 46
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial
2021 · R.A. Cowan, J.J. Scarisbrick, et al. · Journal of the European Academy of Dermatology and Venereology · 43
PDF
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma
2021 · Ellen J. Kim, Joan Guitart, et al. · American Journal of Clinical Dermatology · 42
PDF
Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity
2021 · Ludmila Perelygina, Raeesa Faisthalab, et al. · Frontiers in Immunology · 41
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma
2019 · Jared M. Andrews, Jennifer A. Schmidt, et al. · EBioMedicine · 41
PDF
Update on treatment of cutaneous T-cell lymphoma
2009 · Jennifer M Gardner, Katherine G Evans, et al. · Current Opinion in Oncology · 41
Health‐related quality of life and economic implications of cutaneous T‐cell lymphoma
2019 · Y.R. Semenov, A.R. Rosenberg, et al. · British Journal of Dermatology · 35
Clinical severity measures and quality‐of‐life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology‐specific instruments
2019 · C.M. Herbosa, Y.R. Semenov, et al. · Journal of the European Academy of Dermatology and Venereology · 34
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma
2011 · Christiane Querfeld, Timothy M. Kuzel, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 33
Current measures are not sufficient: an interview‐based qualitative assessment of quality of life in cutaneous T‐cell lymphoma*
2020 · T.S. Bhat, C.M. Herbosa, et al. · British Journal of Dermatology · 28
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic
2020 · John A. Zic, Weiyun Ai, et al. · Journal of the American Academy of Dermatology · 27
PDF
Methotrexate-induced cutaneous ulceration in 3 nonpsoriatic patients: Report of a rare side effect
2017 · Hal A. Lewis, Kathleen M. Nemer, et al. · JAAD Case Reports · 24
Biologics utilization for psoriasis is lower in black compared with white patients
2021 · W.T. Hodges, T. Bhat, et al. · British Journal of Dermatology · 22
Flagellate Erythema in a Patient With Fever
2013 · Heather Ciliberto, Monique Gupta Kumar, et al. · JAMA Dermatology · 22
Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study
2020 · Ellen J. Kim, Larisa Geskin, et al. · Journal of the American Academy of Dermatology · 21
PDF
Works count: 106
Citation count: 2,467
H-index: 22
I10-index: 34
Year
Topic
Type